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 Abstract  
Psychiatric disorders are common, heritable, often chronic and devastating 
illnesses who heavily decline quality of life of the patients and their environment. The 
high genetic correlations across the disorders and their diagnostic criteria reinforce the 
growing discomfort with the current classification and boost the search for more refined 
measurements. Genome-wide association studies (GWAS) are a highly successful 
method for identifying common genetic risk variants underlying common disorders. In 
psychiatric disorders, the emerging picture suggests contribution from a large number 
of single-nucleotide polymorphisms (SNPs) of individually small effect sizes as well as 
rare copy number variants (CNVs) and rare variants discovered by next-generation 
sequencing. Most of these findings have emerged during the last years through large 
collaborative efforts which enabled powerful meta-analyses. Nevertheless, individual 
SNPs and CNVs seem to explain only a minor fraction of the heritable variance for 
psychiatric disorders. Therefore, the development and correct application of novel 
bioinformatics methods is necessary to cope with the limitations inherent to GWAS. 
Biology-informed methods already led to important advances with many discoveries of 
common, rare and de novo variants that are converging on specific pathways and 
biological mechanisms. 
The studies described in this thesis aim to deepen our understanding of 
psychiatric disorders through the application of novel bioinformatics tools to existing 
GWAS data sets. We found evidence that schizophrenia-associated loci contribute to 
the development of bipolar disorder and that the overlapping SNPs converge in 
pathways previously reported in other psychiatric disorders. We revealed two genes 
and a pathway significantly associated with borderline personality disorder previously 
implicated in mental disorders and demonstrated the statistically significant genetic 
overlap with other psychiatric disorders. We identified two pathways suggesting an 
involvement of neurodevelopmental processes in the etiology of bipolar disorder. We 
found that common variants at nine previously reported BD-associated miRNAs do not 
strongly contribute to the differential responses to lithium treatment in BD. Taken 
together, these studies show that the application of biology-informed bioinformatic 
methods enhance the insights gained from GWAS and demonstrate the plethora of 
methods available nowadays. It is the hope that the progress in understanding the 
genetic architecture of psychiatric disorders will also help to improve the clinical 
classification and ultimately yield in better treatment options.  
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1 Introduction 
Mental disorders are among the disorders with the highest non-fatal burden 
(GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, 2017) and 
have devastating effects on the quality of life of patients and their environment. This is 
aggravated by the fact that there is still no satisfactory drug treatment available (Breen 
et al., 2016). Psychiatric disorders are categorized as common disorders with lifetime 
prevalence estimates for anxiety disorders of 28.8% and 20.8% for mood disorders 
(Kessler et al., 2005). A major challenge in the evaluation of biological underpinnings 
of psychiatric disorders is their pronounced heterogeneity. Diagnoses are based on 
structured questionnaires, a combination of various symptoms and a minimal number 
and duration of these symptoms required to fulfill the criteria of a diagnosis (Breen et 
al., 2016; Papassotiropoulos & de Quervain, 2015). Different disease etiologies may 
result in the same clinical diagnosis. Despite these obstacles, substantial heritability 
(h2) estimates have been reported ranging from 0.37 for major depressive disorder 
(MDD) to 0.75 for bipolar disorder (BD) up to 0.81 for schizophrenia (SCZ) (Sullivan, 
Daly, & O'Donovan, 2012). Genome-wide association studies (GWAS) have become 
the major tool in the unbiased investigation of common variants in common disorders 
since their underlying rationale is the “common disease, common variant” hypothesis, 
stating that common disorders are caused at least in part by variants shared by more 
than 1-5% of the population (Pritchard, 2001; Reich & Lander, 2001). Soon after the 
first successful studies of GWAS emerged, consortia were formed to rapidly increase 
sample sizes (Psychiatric GWAS Consortium Steering Committee, 2009). The public 
availability of the GWAS results from consortia accelerated research even further. 
However, the biological interpretation of GWAS results remains a key challenge since 
the function of many single-nucleotide polymorphisms (SNPs) is not well understood 
thereby the interpretation of the respective SNP is mostly based on the gene function 
of the corresponding gene. This may be a reasonable approach, but the mapping of 
SNPs to genes is not without a challenge as they may lie outside gene boundaries. 
Furthermore, even well-powered GWAS have only been able to explain a small portion 
of the phenotypic variance leaving plenty of missing heritability (Manolio et al., 2009; 
Visscher, 2008; Visscher et al., 2017). Despite the success of GWAS it has become 
abundantly clear that this method is just the beginning since testing for association of 
single loci is insufficient in dissecting the complex genetic architecture underlying 
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psychiatric disorders. Gene and gene-set based methods can be seen as 
complementary follow-up approaches since they focus on the joint effect of SNPs. 
Typical gene-set analysis (GSA) approaches aggregate SNPs to genes and then 
aggregate them to sets of genes based on shared properties. These properties can be 
based on biological or functional characteristics and can be retrieved from databases 
or created by the researcher. The application of GSA to GWAS data has proven to be 
a valuable approach since it addresses several limitations characteristic to GWAS. 
GSA enables the interpretation of the joint effect of SNPs with moderate effects on the 
basis of prior biological or functional knowledge which is not possible when only GWAS 
are computed. Due to the polygenic nature of psychiatric disorders the accumulation 
of these variants will empower the detection of genetic risk factors (The Network 
Pathway Analysis Subgroup of the Psychiatric Genomics Consortium, 2015). A bulk of 
GSA methods have been proposed over the years but no gold-standard has been 
defined yet resulting in various challenges like absence of comparability, reproducibility 
and reliability (de Leeuw, Neale, Heskes, & Posthuma, 2016; Mooney & Wilmot, 2015; 
Ramanan, Shen, Moore, & Saykin, 2012; L. Wang, Jia, Wolfinger, Chen, & Zhao, 
2011). Thanks to GSA, not only the biology-based interpretation of GWAS results but 
also the detection of novel variants and genes associated with the disorder is possible. 
Moreover, the easy accessibility of GWAS led to the development of many more 
methods e.g. methods aiming to improve GWAS algorithms by optimizing limitations 
inherent to GWAS (de Leeuw, Mooij, Heskes, & Posthuma, 2015; Loh et al., 2015; 
Svishcheva, Axenovich, Belonogova, van Duijn, & Aulchenko, 2012), methods 
focusing on fine-mapping and deducing causalities (Benner et al., 2016; Bowden, 
Davey Smith, & Burgess, 2015), or methods estimating and partitioning genetic 
variance (Bulik-Sullivan, Finucane, et al., 2015; Bulik-Sullivan, Loh, et al., 2015; 
Finucane et al., 2015; J. J. Lee, McGue, Iacono, & Chow, 2018). Other methods also 
enable the investigation of genetic correlation between disorders or the predictions of 
disease risks (Purcell et al., 2009). The application of these bioinformatics methods 
enabled insights into disease-related biological processes by identifying hundreds of 
low-frequency and common variants that contribute to psychiatric disorders and 
revealed the genetic overlap between disorders (Cross-Disorder Group of the 
Psychiatric Genomics Consortium, 2013; Visscher et al., 2017). But despite all the new 
insights and technical advances in the field, the underlying pathological mechanisms 
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of psychiatric disorders still remain elusive and drug discovery is halting (Fibiger, 
2012). 
This thesis aims to contribute to the field of psychiatric genomics by leveraging 
(publicly) available data-sets and bioinformatics tools primarily focusing on the 
biologically driven computational analysis of bipolar disorder from different angles. To 
achieve this, various gene and gene-set based methods were applied to different 
cohorts enabling the discovery of new susceptibility genes and gene-sets.  
 
This thesis is based on the following four publications. The letters indicate my 
contributions to each publication and are listed after each reference: A - Designed the 
experiment or contributed to the design; B - Performed the experiment; C - Analyzed 
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writing; * - these authors contributed equally.  
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pathways for bipolar disorder and schizophrenia. PLoS ONE, 12(2), e0171595. 
doi:10.1371/journal.pone.0171595 (C-D) 
• Witt, S. H.*, Streit, F.*, Jungkunz, M., Frank, J., Awasthi, S., Reinbold, C. S., . . 
. Rietschel, M. (2017). Genome-wide association study of borderline personality 
disorder reveals genetic overlap with bipolar disorder, major depression and 
schizophrenia. Transl Psychiatry, 7(6), e1155. doi:10.1038/tp.2017.115 (C-D) 
• Mühleisen, T. W.*, Reinbold, C. S.*, Forstner, A. J., Abramova, L. I., Alda, M., 
Babadjanova, G., . . . Cichon, S. (2017). Gene set enrichment analysis and 
expression pattern exploration implicate an involvement of neurodevelopmental 
processes in bipolar disorder. Journal of Affective Disorders. 
doi:10.1016/j.jad.2017.11.068 (A-D) 
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L., . . . Cichon, S. (2018). Analysis of the influence of microRNAs in Lithium 
Response in Bipolar Disorder. Accepted for publication in Frontiers in 
Psychiatry. doi:10.3389/fpsyt.2018.00207 (A-D) 
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2 Theoretical Background  
2.1 Psychiatric disorders  
Mental disorders may be very broadly summarized by problems that people 
experience with their mind and their mood. Their devastating impact on the quality of 
life of patients, their relatives and the society as a whole has been reported widely 
(GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, 2017). One 
of the most frequently used standardized manuals to diagnose psychiatric disorders is 
the Diagnostic and Statistical Manual of Mental Disorders (DSM) of the American 
Psychiatric Association now with its fifth edition released (American Psychiatric 
Association, 2013b). Therein, the diagnosis of a disorders is based on checklists with 
disorders defined by the presence of a minimal number of symptoms, a required 
duration and the associated distress or disability, resulting in clinical heterogeneity 
within disorders (Breen et al., 2016; Papassotiropoulos & de Quervain, 2015). As 
defined by the American Psychiatric Association (2013a), bipolar disorder is a chronic 
mental disease characterized by recurrent episodes of depression and mania or 
hypomania with a mean age at onset of the first episode with approximately 18 years. 
Additionally, patients frequently suffer from co-occurring mental disorders. 
Approximately three-fourths of BD patients suffer from any anxiety disorder and more 
than half from a substance use disorder (Merikangas et al., 2011). This is aggravated 
by the fact that the lifetime risk of committing suicide in people suffering from bipolar 
disorder has been estimated to be at least 15 times that of the general population 
(Marangell et al., 2006). Epidemiological studies revealed unsettling lifetime 
prevalence estimates of 46.6% of participants suffering from at least one of the DSM-
IV disorders assessed (Kessler et al., 2005) with still no satisfactory drug treatment 
available for any disorder (Breen et al., 2016). 
The familial aggregation for most of the major psychiatric conditions has been 
reported since the very beginning of the systematic investigation of psychiatric 
disorders (Kendler & Eaves, 2005). Moreover, early family studies already suggested 
that multiple psychiatric disorders cluster within affected families leading to the 
assumption that heritable factors within and across disorders must exist (Kendler et 
al., 2011).  
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However successful the recent investigation of genetic contributions to 
psychiatric disorders has been, it has also raised concerns such as the categorical 
definition of disorders since genetic analysis clearly suggest a more continuous relation 
between disorders and health (Larsson, Anckarsater, Råstam, Chang, & Lichtenstein, 
2011; Robinson et al., 2016).  
Even though the application of the analysis methods within this thesis was 
mainly to gain insights into the biological underpinnings of BD, it is important to note 
that the methods and strategies can easily be applied to any other psychiatric disorders 
or genetically complex traits in general. 
2.2 Genetic architecture of psychiatric disorders 
Genetic architecture refers to the broad-sense phenotypic heritability since it 
can be summarized as all the characteristics of genetic variation contributing to the 
heritable phenotypic variability (Mackay, 2001). More specifically, this refers to the 
nature and number of genetic variants contributing to a disease, their population 
frequencies and effect sizes and their interactions with each other and the environment 
(Gratten, Wray, Keller, & Visscher, 2014). The exposure of the genetic architecture of 
a complex disorder is elementary when aiming to fully understand its cause of disease. 
An addition to the traditional concept of heritability is the so-called SNP-chip heritability 
(h2SNP) referring to the proportion of variance explained by all variants assayed by 
GWAS arrays (Wray et al., 2014). Estimates suggest that one-third to two-thirds of 
heritability of complex disorders can be explained by common and imputed SNPs 
(Manolio et al., 2009; Visscher et al., 2017; Yang et al., 2013). It is important to keep 
in mind that the human genome not just varies between people on the level of single 
nucleotides but also on a structural level, including copy number variations (CNVs), 
insertions or deletions (INDELs) and translocations (Alkan, Coe, & Eichler, 2011; 
Sudmant et al., 2015). Another distinction is based on the minor allele frequency (MAF) 
of a variant where common, low-frequency and rare genetic variants are defined herein 
as those with a MAF of ≥5%, ≥1% but <5% and <1%, respectively (Welter et al., 2014). 
The architecture of a trait does not only influence the choice of analysis method but 
also the whole design of a study. Since complex traits are assumed to be polygenic, 
the contribution of many, common and ancient variants with small effect sizes are 
implicated resulting in large population-based cohorts and genome-wide analysis 
strategies. Even though this work focuses on common variants the contribution of rare, 
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de novo or structural variants e.g. the recurrent 22q11.2 deletion in SCZ has been 
widely established (Bassett, Marshall, Lionel, Chow, & Scherer, 2008; Kirov, 2015). 
Whole-exome sequencing (WES) and whole-genome sequencing (WGS) studies 
which have only recently become feasible, contribute greatly to the understanding of 
disease mechanisms since they allow the accurate detection of rare and structural 
variants more accurately (Sanders et al., 2017; Zarrei, MacDonald, Merico, & Scherer, 
2015). Interestingly, early micro-array-based studies already allowed to reliably detect 
rare variants (large microdeletions and –duplications covering at least several hundred 
kilobases) associated with psychiatric disorders and suggest that the rare variants 
converge on the same biological pathways as the common variants (Fromer et al., 
2014; Purcell et al., 2014; Schizophrenia Working Group of the Psychiatric Genomics 
Consortium, 2014).  
Pleiotropy describes the phenomenon that a specific variant has an effect on 
multiple traits. This phenomenon has often been described in psychiatric disorders 
(Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013; Pickrell et al., 
2016). Despite the high pleiotropy and phenomenological overlap, studies also 
revealed that the genetic architecture varies between psychiatric disorders with for 
example smaller rates of rare, de novo variants and CNVs in schizophrenia and bipolar 
disorder than in autism (Visscher et al., 2017).  
In the case of BD, GWAS have identified the first susceptibility genes (Cichon 
et al., 2011; Mühleisen et al., 2014; Sklar et al., 2011; Stahl et al., 2018). So far, GWAS 
as well as gene-set analyses have suggested major roles for calcium signal 
transmission, neurodevelopmental genes, and microRNAs/non-coding RNAs 
(Forstner et al., 2015; Mühleisen et al., 2017; Sklar et al., 2011). However, the majority 
of underlying pathways and regulatory networks remain unknown (Nurnberger et al., 
2014). For bipolar disorder, common alleles are estimated to explain 25-38% of the 
phenotypic variance resulting in a substantial part of the heritability unexplained 
(Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013; Sang H. Lee, 
Wray, Goddard, & Visscher, 2011). It is hypothesized that rare variants with higher 
penetrance may contribute to BD susceptibility and account at least for a part of the 
hidden heritability (Cross-Disorder Group of the Psychiatric Genomics Consortium, 
2013; Goes, 2016). This hypothesis may be particularly promising in severely affected 
individuals with a strong family history of the disease. Even though some studies 
suggest an influence of large CNVs in the etiology of BD, it seems that they do not play 
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a major role in BD (Green et al., 2016; Priebe et al., 2012). Preliminary results from 
sequencing studies suggest an enrichment of rare variants in specific gene-sets, such 
as axon guidance, calcium signaling, G protein-coupled receptors and potassium 
channels (Ament et al., 2015; Cruceanu et al., 2017; Fiorentino et al., 2014; Georgi et 
al., 2014; Goes et al., 2016; Strauss et al., 2014). 
As briefly outlined above, impressive progress has been made over the last 10 
years with regard to understanding the genetic architecture of psychiatric disorders. 
Part of this success is attributable to technological (such as SNP microarray and next-
generation sequencing technology) and methodological (GWAS, WES, WGS; 
bioinformatics analyses) developments, part to better insights into the number and 
nature of the involved variants and the enormous sample sizes needed to successfully 
identify them. These findings will enable more accurate and biology-informed 
diagnosis, screenings, prognosis and therapies (Timpson, Greenwood, Soranzo, 
Lawson, & Richards, 2017). 
2.3 Data analytics for common variants 
GWAS were developed to systematically analyze common variants and CNVs. 
One of the first milestone papers in the field of psychiatric genomics was published for 
schizophrenia by O'Donovan et al. (2008). The success of GWAS was accelerated by 
the decreasing costs of genotyping resulting in an excess of GWAS-based 
publications. However, since common variants associated with complex disorders 
individually have small effect sizes it soon became clear that only through consortia 
and large-scale collaborations the sample sizes become large enough to reliably detect 
these effects (Psychiatric GWAS Consortium Steering Committee, 2009). Individual 
variants meeting stringent statistical criteria (genome-wide significance plus 
replication) that were found within these collaborative efforts still only account for a 
fraction of the estimated heritability of the disorders under study. Therefore, improved 
methods allowing a combined view at different genetic factors and better addressing 
the polygenic nature of psychiatric disorders were developed. A method suggested to 
aggregate these individual effects is the polygenic risk score (PRS) analysis that 
captures the effects of all variants below a certain threshold (Purcell et al., 2009). PRS 
have also been used to investigate the variants shared across disorders and 
successfully found genetic overlap not just between psychiatric disorders (Duncan et 
al., 2017; Tesli et al., 2014) but also with psychological phenotypes (Hatzimanolis et 
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al., 2015; Kauppi et al., 2015). LD score regression represents an efficient and 
powerful method not just to estimate the genetic correlation between traits but also to 
estimate the SNP-chip heritability without the need of individual-level data (Bulik-
Sullivan, Finucane, et al., 2015; Bulik-Sullivan, Loh, et al., 2015). A different way to 
combine single variants is the gene-set analysis approach. Methods based on this 
approach rely on the assumption that the aggregation of SNPs within biologically 
meaningful sets of genes has greater statistical power to detect the polygenic 
architecture underlying psychiatric disorders than a single-SNP approach (Ramanan 
et al., 2012). 
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3 Methods  
3.1 Genome-wide Association Analysis 
GWAS were based on the hypothesis that common genetic variants (with low 
to moderate penetrance) explain some of the observed phenotypic variance for 
complex traits (Hirschhorn & Daly, 2005). GWAS do not require a biological hypothesis 
(such as candidate gene studies) and can be applied to discrete or quantitative 
phenotypes. A typical GWAS workflow comprises 5 steps: 1) SNP and sample quality 
control of raw data 2) Principal Component Analysis (PCA) 3) Imputation 4) GWAS 
and 5) Replication or meta-analysis. The following section briefly describes these 
steps.  
First, since millions of SNPs undergo association testing in GWAS, rigorous 
quality control procedures need to be in place. It is crucial for further analysis to filter 
out SNPs and samples that do not meet standard quality control thresholds (Balding, 
2006; Carvalho, Bengtsson, Speed, & Irizarry, 2007; Teo et al., 2007).  
Second, the presence of systematic differences in allele frequencies in 
subgroups possibly due to different ancestry is called population stratification and 
represents one of the major confounding factors in GWAS (Lander & Schork, 1994). 
Owing to this, the genomic inflation factor λ is usually computed to assess whether the 
test statistics are inflated and need to be adjusted. Most often, population stratification 
is corrected for by excluding individuals based on their eigenvalues from PCA or by 
including principal components as covariates in the analysis model later on (L. Liu, 
Zhang, Liu, & Arendt, 2013; Price et al., 2006).  
Third, statistical imputation of unobserved variants is an efficient way to improve 
comparability between different genotyping arrays and studies. It is facilitated by the 
fact that the genotypes of not directly genotyped variants can be estimated by the 
haplotypes inferred from directly genotyped SNPs and the haplotypes observed from 
a fully sequenced reference panel (Biernacka et al., 2009; Delaneau, Marchini, & 
Zagury, 2011; Howie, Donnelly, & Marchini, 2009; Howie, Fuchsberger, Stephens, 
Marchini, & Abecasis, 2012). Genetic Imputation also enables the fine-mapping of 
causal variants and has become a routine step in most GWAS pipelines.  
Forth, linear regression is generally used to perform an analysis on quantitative 
traits and logistic regression on dichotomous traits. Even though other methods are 
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proposed for GWAS, these two are the most frequently used methods since they also 
allow to adjust for confounders. Pe'er, Yelensky, Altshuler, and Daly (2008) postulated 
that a p-value smaller than 5x10-8 should be considered genome-wide significant 
corresponding to the Bonferroni correction for 1’000’000 independent tests, 
representing the estimated number of common variants across the European genome. 
Fifth, to control for false positive findings, the replication of GWAS findings in an 
independent sample or meta-analysis is strongly recommended. Replication studies 
need to consist of a sample size large enough to be able to detect the effect of the 
susceptibility allele. The replication sample needs to be independent but of the same 
population and the identical phenotype must be investigated (Chanock et al., 2007). It 
is vital to validate that the direction of effect of the associated allele is the same in both 
GWAS. However, Skol, Scott, Abecasis, and Boehnke (2006) reported that a joint 
analysis of the replication and the discovery sample together almost always has more 
power than the two-stage approach. Currently, also mega-analysis (a method to jointly 
analyze individual-level data from different studies) are performed, however, statistics 
have shown that meta-analysis are as efficient as a mega-analysis, with the benefits 
of having less privacy restrictions and logistical challenges since only summary 
statistics are shared between groups (Lin & Zeng, 2010). 
3.2 Gene-Based Analysis  
Testing only the associations of single SNPs has been demonstrated to be 
insufficient to dissect the complex genetic architecture of psychiatric disorders. The 
focus on genes rather than single SNPs as the unit of analysis has long been proposed 
and gene-based association scores are now reported more frequently (Hammerschlag 
et al., 2017; Kang, Jiang, & Cui, 2013; Neale & Sham, 2004). GWAS results often are 
difficult to replicate due to factors such as population differences, lack of power, allelic 
heterogeneity or diverse genotyping coverage (Hägg et al., 2015; Yang et al., 2012). 
In contrast, gene-based association analyses are suited to detect genes that may 
increase susceptibility to complex diseases since they are able to aggregate the 
cumulative effect of alleles within one gene and its regulatory region. Since gene 
association scores often are the basis for downstream analysis, it is prudent to carefully 
decide which method to choose. Several methods of how to compute a gene-based p-
value have been proposed, mainly differing in their assumption of the underlying 
genetic architecture. A common and simple way is to choose the most significant SNP 
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to represent the association of the whole gene (Segrè et al., 2010). Albeit this is a fast 
method, it is most sensitive when only one SNP in a gene shows association and 
neglecting the additive effect of SNPs can lead to a loss of power (Ramanan et al., 
2012). Alternatively, the calculation of a mean-based association p-value has been 
proposed, considering all SNPs within the gene boundaries. Still, this measurement 
can be biased by different aspects such as LD, coverage or gene size (de Leeuw et 
al., 2016). Other approaches allow the definition of a user-defined percentage of top 
associated SNPs to be used as a proxy for a gene association score consequently 
excluding SNPs diluting the summary statistics for a gene (Mishra & Macgregor, 2015). 
Novel methods also provide the opportunity to calculate multiple gene-based p-values 
and then aggregate them into a joint p-value which has the advantage of being more 
sensitive to different genetic architectures (de Leeuw et al., 2015).  
The definition of gene boundaries and therefore the assignment of SNPs to 
genes represents an important decision since it may influence not only the power of 
the gene-based analysis but also follow-up analysis such as GSA. The regulatory 
effects of SNPs located outside a gene have been widely demonstrated however the 
inclusion of SNPs within regulatory regions also enables the inclusion of SNPs not 
relevant to the gene (Holmans, 2010; Maston, Evans, & Green, 2006). Definition of 
gene windows ranging from 0kb up to 500kb have been reported in various studies 
(The Network Pathway Analysis Subgroup of the Psychiatric Genomics Consortium, 
2015; Veyrieras et al., 2008; K. Wang, Li, & Bucan, 2007). More recent approaches 
also allow the inclusion of distant SNPs in high LD with genic SNPs (Mishra & 
Macgregor, 2015). The inclusion of SNPs outside the gene boundaries increases the 
possibility of overlapping gene definitions and the number of SNPs that may be 
assigned to more than one gene, therefore potentially leading to an overinflated test 
statistic if not corrected for. This multiple-counting issue becomes even more 
momentous in the context of GSA, where one SNP can account for the strong 
association signals of several genes located within the same target gene-set (Dixson 
et al., 2014; Sedeño-Cortés & Pavlidis, 2014). A prominent region often excluded from 
analysis is the major histocompatibility complex (MHC) on chromosome 6 since it is 
known for its strong LD.  
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3.3 Gene-Set Analysis  
The advantages of analyzing the cumulative effect of genes rather than single 
SNPs has long been discussed and GSA have become a requirement when publishing 
genome-wide association studies. Especially in polygenic traits, the assumption that 
SNPs underlying a disorder are enriched in genes constituting to a set of biologically 
meaningful genes has been widely accepted. Since the development of gene-set 
enrichment methods mainly for gene expression studies, the field has come a long way 
improving the methods not only in their purely computational burden but also the 
awareness and correction of confounding factors yielded in more reliable and 
statistically reproducible results (de Leeuw et al., 2016; Mooney & Wilmot, 2015). 
Nowadays, a broad range of GSA tools are freely available, however, despite some 
differences, the fundamental structures are highly comparable. The typical analysis of 
GSA consists of the following steps: 1) defining target gene-sets 2) formulating null 
hypothesis 3) mapping SNPs to genes 4) calculating gene association scores 5) 
calculating gene-set association scores 6) assessing gene-set significance. 
3.3.1 Gene-Set Definition 
In GSA, gene-sets are defined as a group of related genes that share a 
particular attribute, and the aim is to determine whether this attribute is associated with 
the phenotype of interest. Information on biological pathways and processes is 
available through a vast number of databases differing in e.g. curation-level, organisms 
included or functional areas covered. Reactome is an open access, peer-reviewed and 
well-curated database of biological pathways and processes which is extensively 
cross-referenced to other resources (Croft et al., 2014; Fabregat et al., 2018). Other 
frequently used open-source resources are the Gene Ontology (GO; (Ashburner et al., 
2000; The Gene Ontology Consortium, 2017)) or the Kyoto Encyclopedia of Genes 
and Genomes databases (KEGG; (Kanehisa, Furumichi, Tanabe, Sato, & Morishima, 
2017; Kanehisa & Goto, 2000; Kanehisa, Sato, Kawashima, Furumichi, & Tanabe, 
2016)). Since GO is structured in a hierarchical way, it is necessary to account for the 
vastly overlapping gene-sets when systematically used for GSA. An easy way to 
download annotated gene-sets deriving from various sources is by accessing the 
Molecular Signatures Database (MSigDB, 
http://software.broadinstitute.org/gsea/msigdb/index.jsp). Ingenuity Knowledge Base 
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(Ingenuity Systems, Redwood City, CA, USA), a highly comprehensive and well-
structured database, represents a well-curated but commercial alternative. However, 
researchers are not restricted to limit themselves to previously described gene-sets 
from public resources since the definition of customized target gene-sets such as 
genes known to contribute to a disorder or genes based on a cellular function are a 
promising tool to unravel biological mechanisms underlying diseases (Jansen et al., 
2017; Nurnberger et al., 2014; Thapar et al., 2015).  
3.3.2 Statistical structures of GSA 
Even though a plethora of various gene-set analysis tools exist, only two 
different null hypothesis definitions are applied. The self-contained methods only 
consider genes in the target gene-set and test the association signal within this set 
against no signal. Whereas competitive methods consider all genes and test 
association of genes in the target gene-set against other genes not in this set. The 
competitive method may have less power to detect significant gene-sets when the 
genes associated with the trait are located in multiple gene-sets (Goeman & Bühlmann, 
2007). Nevertheless, the competitive methods are better suited for the analysis of 
polygenic traits since they are able to robustly account for systematic inflation arising 
from various sources whereas self-contained methods are not (Devlin & Roeder, 1999; 
Moskvina, Craddock, Holmans, Owen, & O’Donovan, 2006; Price et al., 2006). Caution 
has to be exercised when interpreting the results gained from a self-contained GSA 
since this method is only able to show how strong the association for some of the 
genes in the gene-set are but not its relevance compared to other gene-sets (Mooney 
& Wilmot, 2015). 
The second main difference between methods is the test statistic used for the 
computation of the gene-set association score where three main approaches can be 
distinguished. The simplest way is to apply a significance threshold to the gene-based 
p-values and count the number of genes designated as significant. A different but 
related approach is to rank the genes based on their p-values and then to check 
whether the target gene-set is enriched for highly ranked genes. Lastly a mean or sum-
based approach can be used to summarize the gene-based p-values within the target 
gene-set (Mooney & Wilmot, 2015; Ramanan et al., 2012). Systematic comparisons 
between methods have shown that mean-based methods yield the greatest power 
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since the ranking and partitioning of genes results in a loss of information (de Leeuw 
et al., 2016). 
Care should be taken when interpreting GSA results since several confounders 
have been reported to introduce significance even though no true relation exists. 
Statistically important factors to consider when applying GSA are the gene-set sizes, 
the size of genes itself and LD between them in the sense that large gene-sets 
consisting of large genes in high LD have the highest risk of becoming significant. The 
inflation of false-positives is especially strong if the most significant SNP was chosen 
to represent the association of the whole gene. Also, high LD between a truly disease-
associated gene with genes not related to the disease can lead to a significant 
enrichment of a non-causative gene-set when these genes cluster within the same 
gene-set (de Leeuw et al., 2016; L. Wang et al., 2011).  
3.3.3 GSA tools 
The main characteristics and differences of the competitive tools used within the 
context of this thesis will be described briefly (see also Table 1). The improved gene 
set enrichment analysis for genome-wide association study version 2 (i-
GSEA4GWASv2) is an easy-accessible, web-based resource based on the 
competitive GSEA algorithm developed by Subramanian et al. (2005) with the 
adaptation of permuting SNP labels instead of phenotype labels enabling the analysis 
of GWAS data. However, the method is not able to correct for the LD patterns between 
SNPs and therefore input data should only consist of a LD-independent set of SNPs 
(Zhang, Chang, Guo, & Wang, 2015). An additional representative of top-SNP 
methods is GSA-SNP with the advantage of using the kth best p-value within each 
gene instead of the traditionally used best SNP expected to result in fewer spurious 
association (Nam, Kim, Kim, & Kim, 2010). Meta-Analysis Gene-set Enrichment of 
variaNT Associations (MAGENTA), an additional top-SNP method based on 
Subramanian et al. (2005), has specifically been designed to analyze summary 
statistics derived from meta-analysis with the benefit of applying an elaborate 
correction algorithm to well-known confounders (Segrè et al., 2010). In contrast, 
INterval enRICHment analysis (INRICH) needs genotype data to create LD 
independent genomic intervals and is characterized by a sophisticated permutation 
scheme enabling the method to account for methodological biases, e.g. multiple 
counting of genes in high LD, effectively (P. H. Lee, O'Dushlaine, Thomas, & Purcell, 
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2012). Since this algorithm relies on independent intervals spread over the genome, 
the method can also be applied when only a subset of SNPs is tested provided these 
loci are independent and could have been distributed all over the genome.  
Multi-marker Analysis of GenoMic Annotation (MAGMA) represents a powerful and 
highly flexible tool enabling the analysis of genes and gene-sets. It is based on a 
regression approach for both gene and gene-set analysis but also consists of more 
traditional approaches making the comparison with other tools fast and easy (de 
Leeuw et al., 2015). Even though MAGMA is a fairly new tool it has become the tool of 
choice for many researchers resulting in publications in various high-impact journals 
(Gandal et al., 2018; Howard et al., 2018; Pardiñas et al., 2018). 
 
Table 1. Overview of GSA methods used 
Method Input Data Hypothesis 
tested 
Test-
statistic 
Description 
i-GSEA4GWASv2 SNP p-
values or 
gene p-
values 
Competitive Rank-
based 
GSEA-based method 
with SNP label 
permutation 
GSA-SNP SNP p-
values 
Competitive Rank-
based 
Uses kth best p-value as 
gene association score, 
offers multiple test 
statistics 
MAGENTA SNP p-
values 
Competitive Count-
based 
GSEA-based method for 
meta-analytic data  
INRICH SNP p-
values 
Competitive 
(self-
contained) 
Count-
based 
Permutation-based 
method that uses LD 
independent genomic 
interval regions  
MAGMA Raw 
genotypes, 
SNP p-
values or 
gene p-
values 
Competitive 
or self-
contained 
Mean-
based 
Regression-based, 
highly flexible and fast 
tool  
 
The application of multiple methods to the same data has been recommended 
since the genetic architecture of complex disorders is not yet entirely clear and 
therefore the most appropriate method may not be determined a priori. Furthermore, 
the so-called technical replication has often been proposed for validation since most 
studies are not able to replicate their GSA findings in an independent sample (Gui, Li, 
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Sham, & Cherny, 2011; The Network Pathway Analysis Subgroup of the Psychiatric 
Genomics Consortium, 2015). 
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4.1 Identification of shared risk loci and pathways for bipolar disorder and 
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5 General Discussion  
Important advances in psychiatric genetics have been made in the recent years, 
with many replicated discoveries of common, rare and de novo variants that are 
converging on specific pathways and biological mechanisms. These successes 
predominantly result from the foundation of international consortia and their combined 
efforts in leveraging resources. Besides getting a better understanding of the genetic 
architecture these efforts also resulted in the development of novel bioinformatics 
tools. These improved tools were developed to cope with the limitations inherent to 
GWAS and ultimately unravel the complete molecular genetic basis of complex 
disorders. The studies described in this thesis aim to deepen our understanding of 
psychiatric disorders by the application of different bioinformatics tools and biological 
information to already existing GWAS data. 
A complete portrait of the genetic architecture for any psychiatric disorder (or 
even any complex disease) does not yet exist. Gaining a more complete knowledge of 
the genetic contributors will therefore be of exceptional importance. To achieve this, 
respect must be paid to both the phenotypic and the genotypic heterogeneity. This is 
of particular relevance for psychiatric disorders, since symptoms are self-reported, 
differing assessment instruments are used, and comorbidities are complicating the 
clear definition of the phenotype (Breen et al., 2016). Furthermore, the misclassification 
of a phenotype, especially in case-control studies, has been shown to dramatically 
reduce the power to detect effects (Edwards, Haynes, Levenstien, Finch, & Gordon, 
2005; Manchia, Cullis, et al., 2013). This is particularly true for BD, where the range of 
symptoms is diverse and overlapping with other disorders such as schizophrenia or 
major depressive disorder (American Psychiatric Association, 2013a). Despite the fact 
that most researchers disagree with the dichotomous concept of the established 
diagnostic and statistical manuals, still no consensus has been found on how to 
improve it (Angst, 2007). Promising approaches to circumvent the phenotypic 
heterogeneity in psychiatric disorder studies and to define more homogeneous 
etiological subgroups are to consider biology-derived phenotypic aspects, such as 
response to drug treatment or endophenotypes, deeply phenotyped samples or 
extreme group comparisons which all already yielded successes (Gershon et al., 2018; 
Gottesman & Gould, 2003; Ibrahim-Verbaas et al., 2016; Manchia, Adli, et al., 2013; 
Peloso et al., 2016; Riglin et al., 2016; Zabaneh et al., 2017). 
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The observed heterogeneity of any psychiatric disorder does not only manifest 
on a phenomenological level but also in the genome. Already early studies revealed 
that a familial overlap among different disorders was present (Kendler et al., 2011). 
Nowadays, with the aid of systematic and well-powered genetic studies, such as 
GWAS, the extensive cross-disorder heritability and high genetic correlations among 
some disorders has been established (Anttila et al., 2017; Cross-Disorder Group of the 
Psychiatric Genomics Consortium, 2013; Witt et al., 2017; Wray et al., 2018). 
Furthermore, GWAS resulted in a plethora of SNPs associated with common 
disorders. However, the effect size of these SNPs is small, and the individual variant 
is neither necessary nor sufficient to cause the disorder. At this point it should be kept 
in mind that GWAS are by design best-powered to detect associations with variants 
that are common in the population (Hirschhorn & Daly, 2005). Due to the relatively 
small effects sizes of the associated variants, it soon became clear that large sample 
sizes are needed to reliably detect susceptibility genes. The combined efforts, the data-
sharing mentality and the ever-increasing sample sizes are just some of the 
advantages of consortia (Psychiatric GWAS Consortium Steering Committee, 2009). 
Future studies investigating common and rare variants will be based on even larger 
sample sizes and as empirical evidence and simulations for GWAS have shown, after 
a certain samples size has been reached, the number of genome-wide significant loci 
will increase linearly (Levinson et al., 2014). Even if the approach of ever-growing 
sample sizes without deep phenotypic information has been widely criticized, it will 
definitely help unraveling the genetic architecture of disorder-specific and cross-
disorder effects (Sullivan et al., 2017). The increase in sample sizes will be continued 
until all most important biological pathways involved in the respective trait/disorder will 
have been identified. However, some limitations are inherent to GWAS and cannot be 
conquered by increasing sample size alone. SNPs identified by GWAS usually don’t 
identify the causal allele or gene itself, more likely the locus implicated several genes 
within the region. In fact, the functional effect of the GWAS hits is rarely understood, 
and the variant often have a regulatory effect on a gene outside the risk locus. The 
common SNPs found by GWAS have been estimated to explain only part, albeit a 
sometimes large part, of the phenotypic heritability for psychiatric disorders. 
Consequently, it could be argued that the so often discussed “missing heritability” is 
actually more likely to be hidden (Eichler et al., 2010; Manolio et al., 2009; Yang et al., 
2010).  
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The discovered polygenicity of psychiatric disorders resulted in the assumption 
that the complex genetic architecture underlying mental disorders is based on sets of 
functionally related genes rather than single independent variants. It is hypothesized, 
that the investigation of these gene-sets will not only yield in a better understanding of 
the disorder but also in improved treatment options (Breen et al., 2016; Smoller et al., 
2018; Sullivan et al., 2012). Based on these assumptions, a wealth of methods that 
leverage GWAS by implementation of biological information was published over the 
last years. Gene-set analysis methods are among the most frequently used novel 
methods since they not only allow the investigation of the joint effects of SNPs but also 
their biological interpretation. The last years have shown that the development and 
accurate application of reliable analysis methods can lead to an enormous increment 
of significant results and enable the in-silico investigation of functional mechanisms 
underlying complex disorders. Even though bioinformatics tools have become more 
user-friendly and consequently open to more researchers, it is indispensable to 
understand the limitations and prerequisites of the methods applied since the over-
interpretation of their results may lead to deceptive results and waste of time, money 
and effort in (functional) follow-up attempts. However, it is not always easy to decide 
which method is best-suited as many, especially older tools are poorly explained. 
The reported studies within this thesis aim to contribute to the field of psychiatric 
genetics by leveraging results from (publicly available) GWAS through applying biology 
informed methods. In the study by Forstner et al. (2017), we systematically 
investigated whether genome-wide significant loci associated with schizophrenia also 
contribute to the development of bipolar disorder. This study is an excellent example 
of the differences arising from comparing publicly available summary statistics. Firstly, 
even though imputation of summary statistics was done to circumvent the fact that 
different panels for the studies were used in the first place, still not all schizophrenia-
associated loci could be investigated in the bipolar data set. Secondly, a complicated 
correction algorithm for the possible sample overlap (in particular for the control 
samples) was applied because neglecting this issue can result in inflated false positive 
rates (Zhu, Anttila, Smoller, & Lee, 2018). Since this study only investigated candidate 
SNPs, merely self-contained methods were appropriate to investigate the combined 
effect of the resulting SNPs associated with both disorders. Interestingly, results of 
both methods identified gene-sets described in earlier studies important in fundamental 
neuronal processes and human diseases such as calcium channel activity or 
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glutamate receptor signaling (Nurnberger et al., 2014; Ripke et al., 2013; Sklar et al., 
2011). These findings are consistent with the previous reported genetic overlap 
between schizophrenia and bipolar disorder not just on the single SNP-level but also 
on the gene-set-level. Even though the combination of different GSA algorithms and 
databases is recommended, it is important to be aware of the specifics each method 
entails and interpret the results accordingly.  
In the study by Witt et al. (2017), we took full advantage of a well-established 
genome-wide analysis pipeline (https://github.com/Nealelab/ricopili) not only to 
systematically investigate borderline personality disorder but also its genetic overlaps 
with other psychiatric disorders. This is of particular interest since borderline 
personality disorder and BD share some of the symptoms and the potential comorbidity 
between these two disorders is an ongoing debate (Fornaro et al., 2016). Since the 
estimated heritability of borderline personality disorder is limited and the genetic 
architecture complex, single marker analysis was unlikely to generate significant 
results with our sample size. Therefore, gene-level and gene-set analysis were 
conducted. To enhance the interpretability of the GSA results, we based our analysis 
on GO-terms solely but replicated the top finding with two independent methods. This 
resulted in a robust association with the gene-set called exocytosis. In neuronal 
synapses, exocytosis is triggered by an influx of calcium and critically underlies 
synaptic signaling. Dysregulated neuronal signaling and exocytosis are core features 
of psychiatric disorders (e.g. autism spectrum disorders, intellectual disability, BIP, 
SCZ and MDD) (Cupertino et al., 2016; Pescosolido, Gamsiz, Nagpal, & Morrow, 2013; 
Sullivan et al., 2008; Zhao et al., 2015). Furthermore, significant genetic correlation 
was found between borderline personality disorder and BD as well as a significant 
correlation between a genetic risk score for BD with borderline personality disorder. 
Since the investigation of single markers did not yield significant associations, this 
study further supports the idea that only the interpretation of the joint effect of SNPs 
will result in meaningful results. However, the results must be interpreted with caution 
since the sample size was small in relation to the estimated heritability.  
The study by Mühleisen, Reinbold et al. (2017) was based on the largest sample 
of BD patients at that time and aimed to extract more biological information by applying 
GSA tools and explored the implicated genes for expression. The implicated gene-sets 
themselves revealed novel insights into the etiology of BD, for example, we found a 
pathway involved in the promotion of cell proliferation, survival, and differentiation, not 
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only in the brain. But it is interesting to mention that plenty of the underlying genes 
have been previously reported to be associated with psychiatric disorders (Cichon et 
al., 2011; Hou et al., 2016; Sklar et al., 2008). However, this study again is a good 
example why it is important to understand not only the algorithms applied but also the 
databases used since one of the most replicated findings in BD (CACNA1C) was not 
even present in the chosen database and therefore had no chance of being found. 
However, these results further support the hypothesis that the genetic underpinnings 
of psychiatric disorders are more likely to function as a set than on a single variant 
basis.  
The last study reported within the framework of this thesis systematically 
investigated the influence of microRNAs in lithium response in BD. Lithium is the best-
established long-term treatment for BD, even though individual response is highly 
variable (Baldessarini, Tondo, & Hennen, 2003; Garnham et al., 2007; Geddes & 
Miklowitz, 2013). The main aim of the study was to investigate whether common 
variants associated with BD also influence the treatment response to lithium. Despite 
the hypothesis-driven approach, no BD-associated microRNA revealed a statistically 
significant association with lithium response. Furthermore, no association between any 
microRNA and treatment response to lithium withstood multiple testing correction. This 
was surprising since evidence from literature pointed not only to a potential link of 
microRNAs and treatment response in various complex disorders but also to an 
involvement in brain development and psychiatric disorders (Campos-Parra et al., 
2017; Fineberg, Kosik, & Davidson, 2009; Hunsberger et al., 2015; Q. Liu et al., 2017; 
Mühleisen et al., 2014; Schizophrenia Working Group of the Psychiatric Genomics 
Consortium, 2014). These results suggest that the genetic factors that contribute to BD 
are different from those contributing to treatment response or illness course. 
Furthermore, the self-contained analysis confirmed that no significant enrichment for 
SNPs at all microRNA loci was observed. However, an important limiting factor in the 
accomplishment and interpretation of this study represents the scarcity of microRNA-
specific information such as expression profiles.  
All the studies reported within this framework aimed to shed additional light on 
the complex genetic architecture underlying psychiatric disorders, and bipolar disorder 
specifically. When comparing the outcomes of the four studies described herein, it 
becomes apparent that each bioinformatics tool has its merits but the shear amount of 
methods available and the often scarcely described parameters applied make it difficult 
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to reliably compare results between studies. Further, it becomes clear that only the 
integrative investigation of all genetic variants together will help to discover the disease 
pathomechanisms. Therefore, not only robust methods and computational resources 
but also large and deeply phenotyped samples will be required for future studies.  
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